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Phospholipid membranear dichroism (SRCD) spectroscopy studies of the eukaryotic pore-forming protein
equinatoxin II (EqtII) were carried out in solution and in the presence of micelles or small unilamellar vesicles
(SUV) of different lipid composition. The SRCD structural data was correlated with calcein leakage from SUV and
withpartitioningof EqtII to liposomes, andmicelles, according tohaemolysis assays. The structure of EqtII inwater
anddodecylphosphocholinemicelles as determined by SRCDwas similar to the values calculated from crystal and
solution structures of the protein, and no changes were observedwith the addition of sphingomyelin (SM). SM is
required to triggerpore formation inbiological andmodelmembranes, butour results suggest that SMalone isnot
sufﬁcient to triggerdissociationof theN-terminal helix and further structural rearrangements required toproduce
a pore. Signiﬁcant changes in conformation of EqtIIwere detectedwith unsaturatedphospholipid (DOPC) vesicles
when SM was added, but not with saturated phospholipids (DMPC), which suggests that not only is membrane
curvature important, but also the ﬂuidity of the bilayer. The SRCD data indicated that the EqtII structure in the
presence of DOPC:SM SUV represents the ‘bound’ state and the ‘free’ state is represented by spectra for DOPC or
DOPC:Chol vesicles, which correlates with the high lytic activity for SUV of DOPC:SM. The SRCD results provide
insight into the lipid requirements for structural rearrangements associated with EqtII toxicity and lysis.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Equinatoxin II (EqtII) is a member of the actinoporin family of sea
anemone toxins that function by forming pores in cell membranes by a
multi-stepmechanism, which includes membrane binding, conforma-
tional change and oligomerisation [1]. The resulting oligomeric pores,
which consist of most likely four monomers, have a radius of about
1 nm [2,3].
The structure of EqtII consists of two short helices packed against
opposite faces of a β-sandwich structure formed by two ﬁve-stranded
β-sheets [4,5]. The currentmodel of pore formationproposes that EqtII
binds to the membrane initially via the aromatic-rich region [6–8],
then the N-terminal α-helical region is transferred to the lipid
membrane [6,9,10] and, ﬁnally, across the bilayer to form a functional
pore [8,9,11]. The structural details of the ﬁnal oligomeric assembly are
not known, but it is clear that pore formation by the actinoporins is61 3 9347 5180.
aribor, Slomškov trg 15, 2000
l rights reserved.quite distinct from the mechanisms adopted by various classes of
bacterial pore-forming toxins [12].
The actinoporins are highly basic proteins of approximately
20 kDa. In model membranes their level of lytic activity depends on
the lipid composition of the target membrane, with lytic activity being
enhanced dramatically by the presence of sphingomyelin (SM) [2,3].
However, it has also been suggested that presence of cholesterol [13]
or lipid domains in the absence of SM [14] may increase permeabilis-
ing activity. It is thus not yet clear if SM may act as a speciﬁc receptor
for the toxin in the lipid membranes or whether the membrane
physical properties enable EqtII to form pores. Some recent studies
provided data that support the former possibility: the interaction of
EqtII with model lipid membranes composed of dimyristoylpho-
sphatidylcholine (DMPC) and SM has been investigated by solid-state
NMR [15], which indicated a preferential interaction between the
toxin and SM. Furthermore, solution NMR studies of the interaction of
EqtII containing ﬂuorinated tryptophans with lipid micelles and
bicelles identiﬁed perturbations in particular regions of the protein in
the presence of SM [16]. However, a key result was that the 19F
resonance of W149 did not change, even in the presence of SM. Thus,
interaction with SM in these model membranes was not sufﬁcient to
trigger dissociation of the N-terminal helix from the β-sandwich,
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was not sufﬁcient to produce the changes associated with pore
formation in the absence of a bilayer.
Fourier transform infrared (FTIR) and circular dichroism (CD)
spectroscopy studies of actinoporins have examined structural changes
of actinoporins upon membrane association. Both methods detected
small increases in β-sheet and α-helical content at the expense of
random structure in the presence of unilamellar phospholipid vesicles
[17–21].However, in the FTIR studies, SMcontributes to the amide signal
in the same region as proteins and hence it is difﬁcult to interpret the
data unambiguously as being due to changes in the protein structure. In
addition, CD spectroscopy in vesicle systems can be difﬁcult to interpret
because of differential light scattering effects present due to the lipid
vesicles [22]. Moreover, the lipid:protein ratios required to eliminate
absorption ﬂattening artifacts [23] and to reproduce conditions that
support pore formation in vitro result in low protein concentrations.
These produce spectra with low signal/noise ratios that make detection
and interpretation of small changes difﬁcult. However, synchrotron
radiation circular dichroism (SRCD) spectroscopy is able to overcome
these problems by utilising a detector geometry that reduces apparent
light scattering [24]. In addition, its higher sensitivity enables the use of
smaller amounts of protein and the high light throughput means that
the lipids, which generally do not produce a signiﬁcant CD signal but do
have signiﬁcant absorbance in the far UV region of the spectrum, do not
degrade the quality of the spectra. Furthermore the ability to acquire
data down to lower wavelengths (around 175 nm instead of 190 nm)
providesmore accurate secondary structure information [25], due to the
additional spectroscopic differences between secondary structural types
at the low wavelengths, as is evident in representative SRCD spectra of
‘standard’ protein structures [24].
In this study the secondary structures of EqtII in aqueous solution,
micelles, and small unilamellar vesicles (SUVs) of different lipid
compositions were determined using SRCD in order to gain a better
understanding of the structural changes in the toxin in the presence of
model membranes. SM, which is required for lytic activity of EqTII, was
added to both phosphocholine micelles and DMPC vesicles and the
effect on EqtII structure was examined. To determine the effect of lipid
order on the toxin, cholesterol was included and SUV of an unsaturated
phospholipid were studied.
2. Materials and methods
2.1. Materials
Dodecylphosphocholine (DPC), dioleoylphosphatidylcholine (DOPC), dimyristoyl
phosphatidylcholine (DMPC) and brain sphingomyelin (SM) were from Avanti Polar
Lipids (Alabaster, AL), and cholesterol (Chol) was from Sigma (St Louis, MI).Fig. 1. SRCD spectra of EqtII in H2O (thick solid line), DPC (thin solid line) and DPC:SM (5:1)EqtII was expressed in Escherichia coli and puriﬁed essentially as described
previously [26].
2.2. Sample preparation
For DPC micelles, DPC was dissolved in deionised (MilliQ) water at a concentration of
2.4 mg/ml (5.7 mM). For SUV samples and the DPC:SM (5:1, mol:mol) sample, lipids were
dissolved in 25% methanol/75% chloroform (v/v) then combined at the desired ratios.
Solvents were removed by rotary evaporation to produce a lipid ﬁlm, which was dried
under vacuum. Lipid ﬁlms were suspended in deionised water and vortexed with glass
beads to producemultilamellar vesicles (MLV) at a concentration of ~5mg/ml. Prior to data
collection, ~800 μL aliquots of theMLVdispersionswere removedby pipette and sonicated
on ice for 30 min with a 20 s on/off cycle, to produce a clear suspension of SUVs. Lipid
samples were mixedwith 46 μL of EqtII stock solution (10 mg/ml) and the pH values of all
solutionswere adjusted to between 6.5 and 7.0. The sampleswere centrifuged at ~6000 ×g
for 2min to remove any large vesicles and thende-gassed for 15min to remove anyoxygen
that would absorb in the vacuum ultraviolet (VUV) region of the spectra.
Sample concentrations were 0.46 mg/mL for EqtII and 3.8–4.8 mg/mL for the
different SUV lipidmixtures, in all cases corresponding to an approximatemolar ratio of
1:250 EqtII:lipid. This proportion was chosen for comparison to our earlier solid-state
NMR studies and electron microscopy of MLV carried out at this protein/lipid ratio,
which showed signiﬁcant bilayer disruption [15]. The EqtII concentration was
calculated from the A280, using a molar extinction coefﬁcient of 36,100 M−1cm−1 [27].
2.3. Synchrotron radiation circular dichroism (SRCD) spectroscopy
SRCD spectra were acquired on beamline CD12 (SRS, Daresbury Laboratory, UK), in a
0.02 cm pathlength Suprasil quartz cell (Hellma UK Ltd, Southend on Sea, UK). Typically,
spectraweremeasured at 25 °C, over thewavelength range 280–175 nm, using an interval of
1 nm and a dwell time of 1 s, with three repeat scans of each sample. The SRCD spectra are
presented here inmean residue ellipticity units (degrees cm2 decimol−1) againstwavelength
(nm). Spectra were processed using CDTool [28]; for each type of sample and baseline
(containing the appropriate lipid), triplicate measurements were averaged, the averaged
baseline was subtracted from the averaged sample spectra and the ﬁnal plot was smoothed
with a Savitsky-Golay ﬁlter. The instrument was calibrated at the beginning of each
synchrotron beam injection using camphorsulfonic acid (CSA), as described previously [29].
SUV stability was veriﬁed by comparison of the baseline SRCD and high tension (HT) spectra
(the latterbeinga typeofpseudoabsorption spectrum)obtainedbothbefore andafter sample
acquisition, with changes in these spectra suggesting vesicle instability or aggregation.
2.4. Analysis of SRCD data
The secondary structure content was calculated using the DICHROWEB server [30]
with the CDSSTR [31], CONTINLL [32] and SELCON3 [33] algorithms. The normalized root
mean square deviation (NRMSD) [34]was calculated as a goodness-of-ﬁt parameter. The
SP175 reference dataset [35] was used for the structure calculations reported as it
includes more representative types of structures and also generally produced lower
NRMSD values than did other available reference data sets [33]. An average of the results
from the three algorithms is reported with +/− values being the standard deviations in
the secondary structures calculated by the three methods. The error bars on the plots
represent the standard deviations in the repeated measurements.
2.5. Permeabilisation of small unilamellar vesicles
Small unilamellar vesicles (SUVs) were prepared as described previously [9] by
sonicating a solution of multilamellar liposomes prepared in the presence of 80 mM(dashed line), at a 1:250 EqtII:lipid ratio. [EqtII] 0.46 mg/ml, pH 7.0, 25 °C, 0.02 cm cell.
Table 1
Calculated secondary structure of EqtII based on SRCD data and estimation of amount of
bound toxin in water, micelles and SUV
EqtII system helix sheet Bound EqtIIa
Water 9% (±4) 44% (±4) –
DPC micelles 11% (±4) 39% (±4) 0%
DPC:SM (5:1) micelles 9% (±4) 43% (±3) 100%
DOPC SUV 9% (±4) 39% (±3) 0%
DOPC:Chol (2:1) SUV 6% (±3) 43% (±2) 0%
DOPC:SM (1:1) SUV 9% (±3) 47% (±2) 91% (±5)
DOPC:SM:Chol (8:1:1) SUV 7% (±3) 47% (±2) 70% (±12)
DMPC SUV 10% (±3) 42% (±3) 0%
DMPC:SM (1:1) SUV 10% (±3) 42% (±2) 49% (±6)
DMPC:SM:Chol (1:1:1) SUV 6% (±2) 44% (±2) 97% (±1)
a Bound EqtII based on haemolysis assay, n=3±S.D.
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sonicated for 30 min with 10 s on and off cycles. After that, vesicles were centrifuged at
top speed in a benchtop centrifuge at room temperature and incubated at 45 °C for
30 min. Lipid compositions used were DOPC, DOPC:SM (1:1), DOPC:Chol (2:1), DOPC:
SM:Chol (8:1:1), DMPC, DMPC:SM (1:1) and DMPC:SM:Chol (1:1:1, mol:mol). To
remove untrapped calcein, the vesicles were applied to a small Superdex G-50 column,
equilibrated in 20 mM Tris–HCl, 1 mM EDTA, pH 7.
Vesicle permeabilisation by EqtII was assayed in a 1.5 mL cuvette (Jasco FP-750
Fluorimeter, Tokyo, Japan). Lipid vesicles at 58 μM ﬁnal concentration were stirred at
25 °C in 20 mM Tris–HCl, 1 mM EDTA, pH 7, then toxin was added at 250:1 mole ratio
(0.23 μM) and ﬂuorescence was followed for 20 min. The maximal release was obtained
by the addition of 2mMTriton X-100 at the end of the assay. No lysis was observed from
SUV without addition of EqtII. The excitation and emission wavelengths were 485 and
520 nm, respectively; both slits were set to 5 nm. The percentage of calcein release (R%)
was calculated as follows:
Rk = Ffin−Finð Þ= Fmax−Finð Þ  100
where Fin and Fﬁn represent the initial and ﬁnal (steady-state) values of ﬂuorescence
before and after peptide addition. Fmax is the ﬂuorescence after the addition of 2 mM
Triton X-100.
2.6. Determination of the bound toxin
The amount of lipid-associated EqtII was estimated by titrating the remaining
free toxin in a microtiter plate hemolytic assay. EqtII at 0.23 μM concentration and
various lipid preparations at 58 μM (lipid/toxin molar ratio around 250) were
incubated for 10 min at room temperature in ﬁnal 200 μL volume of 130 mM NaCl,
20 mM Tris–HCl, pH 7.4. Then the mixture was diluted two-fold across the microtiter
plate and 100 μL of bovine red blood cell suspension (A630=0.5) was added. The
haemolysis was followed at 630 nm for 20 min. The remaining haemolytic activity
was compared to the control EqtII solution, which did not contain any lipids. Mixed
lipid micelles and SUV without EqtII did not induce haemolysis. Three replicates
were done for each lipid preparation.Fig. 2. SRCD spectra of EqtII in DOPC (thin solid line), DOPC:SM (1:1) (dashed line) DOPC:Ch
ratio. [EqtII] 0.46 mg/ml, pH 7.0, 25 °C, 0.02 cm cell.3. Results
3.1. EqtII in water and micelles
SRCD spectra of EqtII dissolved in water and in DPC and DPC:SM
(5:1) micelles are shown in Fig. 1. In water, the calculated secondary
structure of the proteinwas 9% (±4%) helix and 44% (±4%) sheet, which
compares well with the structure determination by NMR (7% helix and
36% sheet) [5] and X-ray crystallography (12% helix and 46% sheet) [4].
There was no signiﬁcant difference in the experimental plots for EqtII
inwater and in DPC or DPC:SMmicelles, which all fall within the error
bars (Table 1) and have the same shape curves (Fig. 1). However, based
on the haemolysis assay (Section 2.6 above), no toxin appeared to bind
to pure DPC (resulting in 100% haemolysis by unbound toxin) while
100% bound to DPC:SM micelles (resulting in no haemolysis).
The calculated values for the secondary structure of EqtII inmicelles
also did not show signiﬁcant differences from that in water, implying
thatmicelles are not sufﬁcient to induce a change in structure, and that
the physical environment of a bilayer may be required. Note that
calculations were also carried out with a new reference dataset that
included membrane proteins [36], but the results were essentially
identical to those using the SP175 reference dataset.
3.2. EqtII with DOPC, SM and Chol bilayers
The SRCD spectra of EqtII added to SUV of DOPC, DOPC:Chol (2:1),
DOPC:SM (1:1), and DOPC:SM:Chol (8:1:1) are shown in Fig. 2. The
addition of EqtII to DOPC:SM:Chol (1:1:1) resulted in the visible
disruption of the vesicles with formation of a white precipitate;
therefore, this compositionwas not analyzed. Lipid bilayers composed
of equimolar unsaturated PC, SM and Chol are thought to contain
microdomains or ‘rafts’ [37], and the addition of EqtII may have led to
vesicle instability and aggregation.
The SRCD spectra with DOPC together with SM or Chol were
signiﬁcantly different from each other as revealed by the shapes of the
curves (with notable increases in magnitude and shifts of the low
wavelength (~190 nm) peak to higher wavelengths when SM was
present). The spectrum of EqtII in DOPC was approximately the same
as that for DOPC:Chol. However, the DOPC:SM spectrumwas radically
different, with the DOPC:SM:Chol being intermediate between the
two. Indeed, principal component analyses [35] showed that the latter
was an average of the other two spectra, which were represented by
two distinct principal components. This suggests that the DOPC:SM
and the DOPC alone (and to a good approximation DOPC:Chol)ol (2:1) (dotted line) and DOPC:SM:Chol (8:1:1) (thick solid line) at a 1:250 EqtII:lipid
Fig. 3. Lysis of SUV by EqtII. The ﬁgure shows the kinetics of calcein release upon
addition of the toxin to a ﬁnal 0.23 μM concentration (at a lipid/toxin ratio ~250) at time
0 s. The permeabilisation is expressed as a percentage of release as compared to the one
obtained by the addition of 2 mM Triton X-100 at the end of the assay. The
representative trace of two measurements is shown.
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that the DOPC:SM:Chol sample is an equilibrium mixture of the two
states. EqtII binding to DOPC vesicles, based on haemolysis testing
(Table 1), appeared to occur only when SM was present, with 0%
binding for DOPC and DOPC:Chol (2:1), 91±5% bound for DOPC:SM
(1:1), and 70±12% bound for DOPC:SM:Chol (8:1:1).
The calculated secondary structures for the DOPC alone samplewere
9±4% for helix and 39±3% sheet, whereas the SUVs with SM showed a
signiﬁcant increase in β-sheet content with values for both DOPC:SM
(1:1) and DOPC:SM:Chol (8:1:1) being 47±2% sheet. (Table 1). All lipid
compositions used for SRCD were also tested for calcein release at the
same lipid/toxin molar ratio (Fig. 3). DOPC vesicles with Chol showed a
small increase in leakage when EqtII was added and maximal lysis was
seen for DOPC:SM (1:1) vesicles, followed by DOPC:SM:Chol (8:1:1),
consistent with this interpretation.
3.3. EqtII with DMPC, SM and Chol bilayers
For comparison, a more ordered phospholipid, the saturated
DMPC, was used instead of the unsaturated DOPC. The spectra for
DMPC:Chol (2:1) and DMPC:SM:Chol (8:1:1) acquired before and after
data acquisition of the EqtII-lipid samples changed due to vesicle
instability and, therefore, the SRCD spectra were not used. The SRCD
spectra of EqtII with DMPC, DMPC:SM (1:1) and DMPC:SM:Chol
(1:1:1) SUV are shown in Fig. 4. The spectrumwith DMPC alone is very
similar to that with DOPC alone and would appear to be of the “free”Fig. 4. SRCD spectra of EqtII in DMPC (thin solid line), DMPC:SM (1:1) (dotted line) and DMPC
25 °C, 0.02 cm cell.state. The SRCD spectrum for DMPC:SM:Chol (1:1) showed a small
difference in shape, which correlates with the lack of overlap of the
error bars on the plots, especially in the low wavelength (~190 nm)
peak. This difference is much less than even the “intermediate” DOPC:
SM:Chol spectrum and suggests an equilibrium with only a small
component (b10%) of the “bound” state. In addition, there were only
small changes in the calculated secondary structure that were not
signiﬁcantwith respect to the standarddeviations in the calculations, i.e.
helix changed from 10±3% to 6±2% and sheet changed from 42±3% to
44±2% (Table1). EqtII didnot appear to bind toDMPC,but ~50% (49±6%)
bound to DMPC:SM (1:1) and almost 100% (97±1%) to DMPC:SM:Chol
(1:1:1) vesicles based on the haemolysis assay (Table 1). The binding
results correlate well with the calcein release data (Fig. 3), where
SUV of DMPC showed no leakagewhen EqtII was added, while DMPC:
SM and DMPC:SM:Chol showed medium and high calcein release,
respectively.
4. Discussion
The SRCD analyses indicated that the secondary structure of EqtII in
water is ~9% helical and 44% sheet, which is intermediate between the
NMR solution structure (7% helix and 36% sheet) and the X-ray crystal
structure (12% helix and 46% sheet). The solution structure [5] was
calculated without TALOS-based backbone dihedral angle restraints,
which are now used routinely and which provide more extensive and
more accurate deﬁnition of backbone conformation than the combina-
tion of NOEs and coupling-constant-based angle restraints used for
EqtII. Hence, the backbone angles in the solution structure deviate
more from the values used to deﬁne canonical secondary structure.
However, if the crystal [4] and solution structures are superimposed,
they agree very well in the regions of the β-strands. The well-deﬁned
region of the N-terminal helix coincides almost exactly in the solution
and crystal structures (i.e. residues 15–26). Moreover, the crystal
structure is a dimer, and the two EqtIImolecules are in contact through
their N-terminal regions, so there is the potential for somedistortion of
local structure. In the solution structure, the second helix spanned
residues 129–134 and is longer in the crystal structure (130–138). The
most signiﬁcant difference between the NMR and X-ray derived
structures occurs around residues 134–138, where the solution
structure is not well-deﬁned and the crystal structure may be affected
by intermolecular contacts in this region. Nevertheless, the SRCD
analyses yield secondary structure contents that are consistent with
the solution and crystal values, and validate the use of the method for
examining the secondary structure of this protein.:SM:Chol (1:1:1) (thick solid line) at a 1:250 EqtII:lipid ratio. [EqtII] 0.46 mg/ml, pH 7.0,
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micelles, either with or without SM present, no signiﬁcant net sec-
ondary structural change occurs. 19F NMR data [16] suggested that
with DPC:SMmicelles the N-terminal region of EqtII did not dissociate
from the bulk of the protein. Local changes were detected in the region
of Trp112 when SM was added to DPC, but this localized type of
changewould not be detected by SRCD. Both studies, however, suggest
that the mere presence of SM is not in itself sufﬁcient to cause a major
conformational change, which may require the presence of a lipid
bilayer structure.
The results for SUV with unsaturated and saturated PC contrasted
with those in micelles, where the conformation of the toxin appeared
to be the same as for EqtII in aqueous solution. The interactions of EqtII
with SUV composed of the unsaturated phospholipid DOPC, DOPC:SM
(1:1), DOPC:Chol (2:1) and DOPC:SM:Chol (8:1:1) were studied.
Vesicles with equimolar Chol and SM were used since Chol favours
phase-separation of SM [38] and formation of lipid raft-like domains
[37]. For comparison, interaction with the saturated phospholipid
DMPC, DPMC:SM (1:1) and DPMC:SM:Chol (1:1:1), which formed
stable SUV, was also studied. The DOPC vesicles with SM and Chol
form a disordered liquid crystalline phase whereas DMPC vesicles
with SM and Chol would be in a more ordered phase [39], which may
prevent the toxin inserting and resulting in a similar secondary
structure content as for EqtII in water. The main gel–ﬂuid phase
transition temperature for DOPC is low (−17 °C) compared to DMPC
(23 °C) [40], so that SUV of DMPC:Chol (2:1) and DMPC:SM:Chol
(8:1:1) were unstable at 25 °C [41,42] and, therefore, data from these
DMPC samples were not used. SUV of DOPC with SM and Chol were
more stable, but when EqtII was added to DOPC:SM:Chol (1:1:1) SUV,
a precipitate formed, suggesting that the toxin led to aggregation of
the vesicles.
When EqtII was added to DMPC:SM:Chol (1:1:1) vesicles, binding
appeared to increase to almost 100% and a signiﬁcant spectral change
was detected. This change, which involved only the low wavelength
region (and, therefore, would not have been detectable with
conventional CD spectroscopy), does not appear to correlate with
the expected increase in helix content and concomitant decrease in
β-sheet (see below). Paradoxically, the shift to higher wavelengths
in the 190 nm region (Fig. 4) would be consistent with an increase in
β-sheet, although this would not be consistent with the increase in
magnitude. However, the shift may in fact be attributable to several
other features: 1) association with membranes can cause spectral red-
shifting of the ~190 nm peak [43], so the observed difference could be
partially attributable to this, although the magnitude of the shift
observed is larger than expected; 2) interaction of structural elements
canproduce lowwavelength (b200nm) changesdetectable by SRCDbut
not readily detectable by conventional CD [44]; and 3) signiﬁcant
changes in aromatic environments can have some effect in the low
wavelength region of the spectrum normally attributed only to
secondary structure. This may result from local changes in the vicinity
of the ﬂuorinated Trp residues of EqtII observed in the presence of lipid
micelles by 19F NMR [16].
When the toxin interacts with lipid bilayers, the largest change in
structure is likely to be the result of dissociation of the N-terminal
region from the β-sandwich and concomitant association with the
lipid in a helical conformation [9,11,45]. This conformational change is
necessary for pore formation, but is probably not sufﬁcient, as the
functional pore requires the association of most likely four EqtII
molecules to form a tetramer. From the present SRCD data we are
unable to distinguish between the conformational changes associated
with lipid binding and those associated with pore formation (the
latter correlating with lytic activity), but we can detect a signiﬁcant
conformational change that occurs in the DOPC bilayers when SM is
present. This is consistent with the observation that EqtII does not lyse
DOPC or DOPC:Chol signiﬁcantly but does lyse DOPC:SM and DOPC:
SM:Chol vesicles (Fig. 3). EqtII added to DOPC:SM and DOPC:SM:Cholshowed the greatest change in conformation by SRCD (Fig. 2). The
observed differences in structure and binding observedmay be related
to the order of the lipid, with DOPC being the more ﬂuid and possibly
allowing protein unfolding or insertion into the bilayer in the presence
of Chol and SM.
Although no toxin appeared to be bound to pure DPC micelles,
100% was bound and no longer active in haemolysis assays when EqtII
was added to DPC:SM (5:1) micelles. These results are thus in
agreement with the current model of EqtII interaction with mem-
branes, where the toxin interacts with DPC only via the exposed
residues, including Trp112, from the broad loops at the bottom of the
molecule, but dissociation of the N-terminal helix to the lipid
membrane and further structural rearrangements to produce a pore
structure does not occur. The SRCD data indicate that the EqtII
structure represents the ‘bound’ state in the case of DOPC:SM and the
‘free’ state for DMPC vesicles, which correlates with high and no lytic
activity, respectively. The changes in conformation of EqtII detected in
the more unsaturated phospholipid, DOPC, suggest that not only is
membrane curvature important, but also the ﬂuidity of the bilayer.
Taken together, these studies suggest that SM alone is not sufﬁcient to
trigger dissociation of the N-terminal helix, which may require the
context of a ﬂuid bilayer.
In summary, SRCD studies of EqtII in solution, micelles and lipid
bilayers of different composition have provided insight into the lipid
requirements for structural changes associated with toxicity and lysis.
Such studies could not have been done using conventional CD spectro-
scopy, as they required high lipid/protein ratios, the presence of lipid
bilayers, and the ability to measure data accurately at low wavelengths.
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